The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Itaconix® TSI™ 322 is the brand in Dish washer tablets
if ITX was to sell the IP rights of Itaconix® TSI™ 322 then alone this could fetch £30 Million based on future earnings and major take up of the industry over its life span now.
I’ll take those numbers AJP! & looking forward to the next update from John. What is really really exciting here is that we’re only just moving off the start of what will be a great growth curve. Here’s hoping for a great week.
ATB
Hi Dougerboy
That was how I was reading it, so glad we have come to the same conclusion.
I guess the GM level will be dictated in some respect by the larger players, large repeat orders commanding a more competitive price and for me the dishwasher products would have the lowest GM.
Would love to see the first quarter numbers as this will set the trend for the rest of the year.
John did say that we had made profit in some of the months last year, this year I think it will be every month and we will produce Stella figures for 2021
My predictions based on the fact we always have a stronger finish to the year, dictated by demand cycle, we have 3 new major product launches and continued take up by new and existing customers.
These numbers I feel may be on the conservative side.
1st quarter $1 mill
2nd quarter $ 1.2 Mill
3rd quarter $ 2mill
4th quarter $ 2.5 Mil
Total for the year 2021 $ 6.7 mill
AIMHO
ATB
AJP
Hi AJP, I think, from what I can see, the deferred consideration was from 2017-2020. So that ship has sailed. For 2021 it all looking very positive isn’t it? Looking at 2020 full year numbers we need to add $3.5-$4M onto the 2020 number to around around $7M annual revenues to be at breakeven level with current cost structure and GM level of 35%. Given John Shaw’s confident outlook that seems highly for 2021. But I’m not bothered if it’s mid 2022. He did mention, though, during the 2020 results presentation that GM by product can vary widely, from 20 % up to 60%. Hopefully we’re selling loads of the 60% GM stuff!
Thanks Dougerboy
was just trying to get my head round the timescale, is this an annual bonus, performance related until the agreed maximum amount has been reached, or was this only applicable for revenues up to and including year end 2020?
Change days eh, from the document.would not like to try and estimate the number of brands now.
Itaconix’s products are high margin and are currently used in over 20 home care brand products found in major and specialty retailers across North America and Europe.
Have you sat down and looked at what you think the potential figured for 2021 will be in your opinion? Just looking to see if there is a consensus figure.
ATB
AJP
Hi AJP, my interpretation is there is no additional deferred compensation due up to FY20 inclusive. Here is the key line:
“In addition, deferred performance related consideration will be payable to the Itaconix Stockholders, subject to the achievement of certain growth targets for the calendar years 2017 to 2020, based on 50% of incremental annual net sales above $3 million in 2017 and in excess of the prior year for 2018 to 2020 inclusive.”
Looking forward to an onwards and upwards trajectory this year and beyond. Will take out my original investment at some point and leave the rest for a long free ride.
Had a little dig for information based on the performance related allocation of shares on Friday, obviously demonstrates that the company is doing extremely well, before this has come into play. If I have read the document correctly 2020 is the last financial year for which this applies, please correct me If I have interpreted this wrongly.
https://itaconix.com/wp-content/uploads/160620-Project-Romeo-opening-announcement-FINAL-1.pdf
Think on the back of this that we might see and update in the next week or so with the 1st quarter figures, which I think will demonstrate that we are going from strength to strength.
Well done to those who have managed to take some profit during the current rise.
Holding tight here as I feel there is still a lot of upward movement to go before I would consider reducing my considerable holding, definitely a once in a generation stock to be involved in, where its technological expertise in producing eco friendly polymers is becoming the staple ingredient of major brands throughout the world.
AIMHO
DYOR
Have a good weekend
AJP